DARPA's June 3 Drop: Rydberg Atomic Sensors, Cognitive Sleep, Closed-Cycle Power, and Pathogen Interactome — Five FY26 SBIR/STTR Topics Closing July 22

DARPA's pivot from the old twice-a-year Broad Agency Announcement model to a continuous monthly drip of small, sharply-scoped Small Business Innovation Research and Small Business Technology Transfer topics is now in its third year, and the cadence has stabilized. The May 27 Microsystems Technology Office drop carried six topics with a June 24 close. The June 3 pre-release from the Defense Sciences Office and the Biological Technologies Office carries five more, all opening June 24 and closing July 22, 2026 at noon Eastern. Each is structured as a four-week proposal window against a Phase I or STTR Phase I scope, with selection decisions in fall 2026.

The five-topic June 3 drop — MANTRAS, Engineering Sleep for Cognitive Performance, ExCAIPE, Real-Time Pathogen-Host Interactome Prediction, and the STTR Biomanufacturing of Hierarchical Biocomposites — covers an unusually wide span of DARPA's portfolio for a single release, and the topics are worth reading together because the bundle reveals something about how the agency is thinking about technology maturation and small-business participation as the FY26 budget environment tightens.

This post walks through the five topics, the technical and team-composition signals embedded in each, the implications of DARPA's continuous-release cadence for first-time SBIR applicants, and the practical decision framework for whether to push for a July 22 submission or wait for the next drop. Granted's SBIR/STTR Deadlines Calendar tracks the full agency-by-agency rolling schedule for FY26.

The Five June 3 Topics

The five topics span Defense Sciences (Quantum sensing, human performance, power and energy), Biological Technologies (pathogen biosurveillance), and the STTR program (biomanufacturing). Each topic codes maps to a specific Phase and DARPA office under the FY26 numbering scheme.

DPA26BZ03-DV011 — MANTRAS (Manufacturing Technologies for Rydberg-based Atomic Sensors) — is a Defense Sciences Office SBIR XL topic targeting the manufacturing maturation of Rydberg atom-based sensors. Rydberg sensors use highly excited atomic states to detect electromagnetic fields with extraordinary sensitivity and broad spectral coverage, and they have moved over the past five years from physics-lab curiosities to credible candidates for radar receivers, GPS-free position-navigation-timing, and communications-electronic warfare systems. The bottleneck is manufacturing: the laser, vacuum, and atom-source subsystems that work in laboratory settings have not been productized for the cost, size, and reliability the Defense Department needs. DPA26BZ03-DV011 funds Phase I work to mature manufacturing processes — laser stabilization, vapor-cell fabrication, atom-source production, optical assembly — rather than fundamental sensor physics. The strongest applicants will be small companies with hands-on photonics, vacuum, or precision-assembly manufacturing experience, paired with university or national-lab partners that bring the Rydberg atomic physics expertise. Pure-research teams without a manufacturing thesis will not score well here.

DPA26BZ03-DV012 — Engineering Sleep for Cognitive Performance — is a Defense Sciences Office SBIR XL topic in DARPA's human performance line, targeting sleep architecture interventions that improve cognitive performance during operationally constrained sleep windows. The topic explicitly references both pharmacological and non-pharmacological interventions and asks for proposals that combine a measurable cognitive performance endpoint with a sleep-stage manipulation modality. The strongest applicants will be teams that combine sleep-medicine expertise, validated cognitive assessment instruments, and a credible Phase II commercialization path — DARPA wants interventions that can scale to operational use, not just lab demonstrations. Wearables companies, neuromodulation startups, and small pharmaceutical teams with active IND-stage compounds are well-positioned. Teams without an obvious endpoint and validated cognitive assessment will struggle.

DPA26BZ03-DV013 — ExCAIPE (Expeditionary Closed and Air-Independent Power and Energy) — is a Defense Sciences Office SBIR XL topic targeting closed-cycle and air-independent power systems for expeditionary use. The topic sits in the broader DARPA portfolio of small-form-factor energy systems and explicitly asks for technologies that can deliver useful electrical power without atmospheric oxygen — relevant for underwater, underground, and contested-air-environment use cases. Candidate technologies include closed-Brayton-cycle systems, solid-oxide fuel cells with stored oxidizer, thermoelectric and thermophotovoltaic converters paired with radiothermal or chemical heat sources, and small-form-factor nuclear batteries. The DARPA Office of Strategic Research is interested in systems that hit specific power-density and runtime thresholds in Phase II, so Phase I proposals should be explicit about how the proposed approach reaches the Phase II target. Small companies with prior DOE, Navy ONR, or NASA closed-cycle power work are the natural applicants.

DPA26BZ03-DV014 — Real-Time Pathogen-Host Interactome Prediction — is a Biological Technologies Office SBIR I topic in DARPA's pandemic preparedness portfolio. The topic asks for computational tools that predict, in near real-time, the host-cell interactions of newly identified pathogens — the protein-protein, protein-RNA, and protein-DNA interactions that determine virulence, tropism, and host range. The target is to compress what is currently a months-long wet-lab process into a hours-to-days computational prediction that can guide diagnostics, therapeutics, and biosurveillance during the first week of a novel outbreak. The strongest applicants will be teams combining machine-learning expertise (specifically, the structural-biology foundation models that have matured over the past three years) with experimental validation capacity. Pure-software teams without a wet-lab validation path will not score well; DARPA learned from the COVID-era prediction efforts that unvalidated predictions are operationally useless.

DPA26TZ03-DV002 — Biomanufacturing of Hierarchical Biocomposites — is the STTR Phase I topic in the drop, targeting biomanufacturing approaches that produce hierarchically structured biocomposite materials at scale. The STTR designation requires a small-business prime with a research-institution partner that performs at least 30 percent of the work. The materials in scope include engineered cellulose-based composites, silk-mineral hybrids, and other biologically-templated structural materials with specific strength, toughness, or environmental-response properties. The strongest applicants will be teams that have already demonstrated lab-scale biomanufacturing of a specific composite and can credibly propose a Phase II scale-up path. As with MANTRAS, this is a manufacturing topic, not a fundamental materials science topic, and reviewers will weight manufacturing readiness heavily.

What the Bundle Signals

Three things stand out about the June 3 drop when the five topics are read together.

First, four of the five topics are SBIR XL — DARPA's larger Phase I award category, with award ceilings substantially above the standard SBIR I cap. The XL designation has been DARPA's mechanism for funding Phase I efforts that need real prototype hardware or wet-lab validation, not just paper studies, and the concentration of XL topics in this drop signals that DSO is prioritizing topics where Phase I deliverables need to be more than feasibility memos. Applicants targeting XL topics should plan Phase I budgets and timelines that reflect actual hardware or biological work, not the lighter feasibility scope that earlier Phase I awards tolerated.

Second, two of the five topics — MANTRAS and Biocomposites — are explicit manufacturing-maturation topics rather than fundamental research topics. That continues a pattern visible across DARPA's FY26 release schedule: the agency is increasingly using SBIR to mature technologies that have demonstrated lab feasibility but lack a manufacturing path. For small companies, that is good news — manufacturing-maturation topics favor teams with industrial process expertise over teams with publication records — but it changes the proposal structure. Reviewers will look for a clear manufacturing thesis, an articulated cost model, and a credible Phase II scale-up path, not an extended introduction to the underlying science.

Third, the BTO Pathogen Interactome topic and the human-performance Sleep topic both target operational endpoints with explicit validation requirements. The lesson from the past three years of DARPA pandemic-related funding is that unvalidated computational predictions failed in deployment, and DARPA has built that lesson into the topic structure. Proposals that combine a software approach with a wet-lab or human-subjects validation path will outscore proposals that propose either alone.

The Continuous-Release Cadence and What It Means for Planning

DARPA's shift away from twice-a-year omnibus BAAs to monthly small drops has been gradual since 2023. The cadence is now consistent enough that small-business teams can plan around it: a new drop drops on roughly the first or second Tuesday of each month, topics open about three weeks after pre-release, and the proposal window is roughly four weeks. That means a team monitoring DARPA's SBIR/STTR topics page and the DoD SBIR/STTR Innovation Portal has six to eight weeks of warning on every topic, but the formal proposal window is short.

The practical implication is that teams cannot wait for a topic to drop before assembling the team and capabilities. Successful Phase I proposals in the continuous-release era are built by teams that maintain a baseline capability set in a specific technical area and then quickly tailor a proposal when the matching topic appears. Teams that try to assemble a team and write a proposal inside the four-week window almost always lose to teams that had the team in place. The MANTRAS, ExCAIPE, and Biocomposites topics in particular reward teams that have been doing work in the area for at least a year and can move quickly from topic release to a fully-staffed proposal.

For first-time SBIR applicants, the question is whether to push for the July 22 deadline or wait for the next drop. The honest answer is that first-time applicants without a baseline capability set should almost always wait. Phase I proposals that are written from scratch in four weeks rarely win against teams with existing positioning, and a poorly-scored Phase I proposal damages the team's standing for future submissions. The right move for a first-time team is to use the July 22 window to study the proposal structure, build relationships with potential research partners, and position for the August or September drop with a topic that better matches existing capabilities.

For teams with existing capabilities in one of the five topic areas, the July 22 deadline is a real opportunity. The bundle is unusually broad for a single release and the SBIR XL designation on four of the five raises the funding ceiling. Submissions will be due July 22 at noon Eastern through the DoD SBIR/STTR Innovation Portal, with selection decisions expected in fall 2026 and Phase I performance windows starting in early FY27.